Priority-setting rationale
The first step is to recognize that this client is exhibiting
opioid-induced respiratory depression from
intrathecal morphine administered
8 hours ago. The combination of a
respiratory rate of 10/min,
SpO2 94% on room air, and
falling asleep in the middle of a sentence indicates progressive sedation that precedes respiratory arrest. Sedation always occurs before opioid-induced respiratory depression becomes life-threatening, so the nurse must intervene at the level of arousal and ventilation before addressing other morphine-related effects.
Why breathing is the immediate priority
Intrathecal morphine migrates rostrally in the cerebrospinal fluid and can depress the brainstem respiratory centers for up to
24 hours after injection . The client’s sedation level corresponds to
Pasero Opioid-Induced Sedation Scale level 3—sleeping but arousable, falling asleep during conversation—which is a
Watch out! warning sign that respiratory depression is developing. A respiratory rate of
10/min with marginal oxygenation confirms that ventilatory drive is already compromised. The nurse must stay with the client, rouse her, coach deep breathing, and apply oxygen to support ventilation and oxygenation immediately.
Why the other options are secondary
Urinary retention with a palpable bladder and facial/chest pruritus are both well-documented adverse effects of intrathecal morphine
[2]. However, neither is immediately life-threatening. Catheterization for bladder distention and antihistamine administration for itching can be safely deferred until the airway, breathing, and circulation are stabilized. Notifying the anesthesia provider is appropriate but should occur after the nurse has initiated direct interventions to support breathing; the provider will likely order
naloxone and increased monitoring, but the nurse’s first action is at the bedside.
| Assessment finding | Clinical significance | Priority |
|---|
| RR 10/min, SpO2 94%, sedation level 3 | Opioid-induced respiratory depression; sedation precedes apnea | Immediate—support breathing and oxygenation |
| Bladder palpable above pubis, no voiding for 6 hours | Urinary retention from intrathecal morphine | Delayed—catheterize after respiratory stability |
| Facial and chest pruritus | Morphine-induced histamine release or central pruritus | Delayed—antihistamine after respiratory stability |
| Firm fundus, moderate lochia | Normal postpartum uterine tone and bleeding | Reassuring—continue routine monitoring |
Monitoring implications from the evidence
The Society for Obstetric Anesthesia and Perinatology recommends respiratory monitoring after cesarean delivery based on intrathecal morphine dose, reflecting the recognized risk of delayed respiratory depression . Dose-dependent adverse effects, including sedation and respiratory depression, support the trend toward lower intrathecal morphine doses, but even standard doses require vigilant nursing surveillance . The nurse’s role is to detect early sedation changes and intervene before respiratory failure progresses.
Rousing the client, coaching deep breaths, and giving oxygen directly addresses the reversible cause of hypoventilation and buys time for pharmacologic reversal with naloxone.
Key point! Sedation level is the earliest and most reliable clinical indicator of impending opioid-induced respiratory depression; a client who falls asleep mid-sentence requires immediate stimulation and respiratory support, not just observation.
References (research sources)